Terms: = Prostate cancer AND CCND3, P30281, 896, ENSG00000112576 AND Staging
6 results:
1.
Sheikhbahaei S; Jones KM; Werner RA; Salas-Fragomeni RA; Marcus CV; Higuchi T; Rowe SP; Solnes LB; Javadi MS
Ann Nucl Med; 2019 May; 33(5):351-361. PubMed ID: 30877561
[TBL] [Abstract] [Full Text] [Related]
2. Can multiparametric MRI replace Roach equations in staging prostate cancer before external beam radiation therapy?
Girometti R; Signor MA; Pancot M; Cereser L; Zuiani C
Eur J Radiol; 2016 Dec; 85(12):2231-2237. PubMed ID: 27842672
[TBL] [Abstract] [Full Text] [Related]
3. Comparison of bone scintigraphy and
Pyka T; Okamoto S; Dahlbender M; Tauber R; Retz M; Heck M; Tamaki N; Schwaiger M; Maurer T; Eiber M
Eur J Nucl Med Mol Imaging; 2016 Nov; 43(12):2114-2121. PubMed ID: 27290607
[TBL] [Abstract] [Full Text] [Related]
4. Pathological stage T2 subgroups to predict biochemical recurrence after prostatectomy.
Kordan Y; Chang SS; Salem S; Cookson MS; Clark PE; Davis R; Herrell SD; Baumgartner R; Phillips S; Smith JA; Barocas DA
J Urol; 2009 Nov; 182(5):2291-5. PubMed ID: 19758638
[TBL] [Abstract] [Full Text] [Related]
5. E-cadherin gene 3'-UTR C/T polymorphism is associated with prostate cancer.
Wu HC; Lai MT; Wu CI; Chen HY; Wan L; Tsai FJ; Chen WC
Urol Int; 2005; 75(4):350-3. PubMed ID: 16327305
[TBL] [Abstract] [Full Text] [Related]
6. Statistical validation based on parametric receiver operating characteristic analysis of continuous classification data.
Zou KH; Warfield SK; Fielding JR; Tempany CM; William MW; Kaus MR; Jolesz FA; Kikinis R
Acad Radiol; 2003 Dec; 10(12):1359-68. PubMed ID: 14697004
[TBL] [Abstract] [Full Text] [Related]
